Rick Altice, MD, MA

Professor of Medicine (Infectious Diseases) and of Epidemiology (Microbial Diseases); Director, Clinical and Community Research; Director, HIV in Prisons Program; Director, Community Health Care Van; Academic Icon Professor of Medicine, University of Malaya-Centre of Excellence for Research in AIDS (CERiA)

Departments & Organizations

School of Public Health: Center for Interdisciplinary Research on AIDS | Epidemiology of Microbial Diseases

AIDS Care Program

Dean's Advisory Council for LGBTQI Affairs: Directories: Research Interest | Yale Medicine Outlist

Internal Medicine: Infectious Diseases: AIDS Care Program; Clinical & Community Research (YCCR) | Viral Hepatitis Program

Office of International Medical Student Education

Yale Institute for Global Health

Yale Medicine

Global Health Studies

Office of Cooperative Research


Frederick L. Altice is a professor of Medicine, Epidemiology and Public Health and is a clinician, clinical epidemiologist, intervention and implementation science researcher at Yale University School of Medicine and School of Public Health. Dr. Altice’s primary research focuses on interventions and implementation science at the interface between infectious diseases and addiction and he has conducted research in several global health settings. He also has a number of projects working in the criminal justice system, including transitional programs addressing infectious diseases, medication-assisted therapies (methadone, buprenorphine, extended release naltrexone), mental illness, homelessness and social instability. Specific topics include alcohol, opioid and nicotine use disorders on HIV treatment outcomes, HIV and addiction treatment, interface with the criminal justice system, and pharmacokinetic drug interactions between treatment for substance use disorders and antiretroviral and tuberculosis therapy. At a basic level, his research focuses on clinical epidemiology, especially in key populations at risk for HIV (e.g., MSM, TGW, PWID, prisoners, sex workers) and development, an adaptation and evaluation of of biomedical and behavioral interventions to improve treatment outcomes. His research, however, has evolved and included development and testing of mobile technologies (mHealth) to intervene with key populations in more effective ways.  His research is especially concentrated in health services research techniques with a focus on implementation science, seeking to introduce and scale-up evidence-based interventions in numerous contexts. A number of implementation science strategies are underway to examine scale-up of medication-assisted therapies to treat opioid use disorder in community, criminal justice and in primary care settings. Most recently, his work has been augmented through use of decision science techniques to understand and promote patient preferences, including the development of informed and shared decision-making aids. His work has emerged primarily with a global health focus with funded research projects internationally in Malaysia, Ukraine, Central Asia, Peru, and Indonesia. He has participated in projects through the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Agency, Special Projects of National Significance with HRSA, and the Center for Substance Abuse Treatment. He is currently also collaborating on projects with the WHO, UNAIDS, USAID, PEPFAR and UNODC. Current internationally funded projects in dedicated research sites that are being conducted in Malaysia, Ukraine, Moldova, Azerbaijan, Armenia, Kyrgyzstan and Peru. His research and training sites in Malaysia (2005), Peru (2010) and Ukraine (2005) are dedicated training and research sites for the Global Health Equity Scholars Fogarty Training Program and the Doris Duke International Fellowship program.

Education & Training

MA Yale University, Honorary (2008)
MD Emory University (1986)
Fellow Yale University School of Medicine
Resident Yale University School of Medicine
Board Certification AB of Internal Medicine, Internal Medicine (1989)

Honors & Recognition

  • Most Influential Paper on Addictions - 2016 (Lancet)European Monitoring Centre for Drugs and Drug Addiction (2017)

  • Appointed as Academic Icon Professor of Medicine, Centre for Excellence in Research in AIDS (CERiA) at University of MalayaInfectious Diseases Unit, Department of Medicine, Faculty of Medicine, University of Malaya (2009)

  • Board of Permanent OfficersYale University School of Medicine (2009)

  • National Hope is a Vaccine" Award RecipientGAIA, Global Alliance to Immunize against AIDS (2008)

Professional Service

  • (2009 - Present) World Health Organization Guidelines Committee for Treatment of HIV and Tuberculosis Among Drug Users.

  • (2009 - Present) Symposium Chair, International AIDS Society Conference, 2009, Cape Town, South Africa

  • (2009 - Present) American Board of Correctional Medicine

  • (2009 - Present) Board of Permanent Officers, Yale Univ. School of Medicine

  • (2008 - 2009) Yale School of Medicine M.D. Thesis Mentor Council. Office of Student Research.

  • (2008 - Present) Correctional Academic Liaison Meeting (CALM), CT. Department of Corrections.

  • (2008 - Present) Addiction, Journal of General Internal Medicine, International Journal of Prison Health Care

  • (2008 - Present) The Open Public Health Journal, Open Infectious Diseases Journal, International Journal of Prisoner Health

  • (2008 - Present) Executive Board, Liberty Community Services, Inc. New Haven CT.

  • (2007 - Present) Research Director, AIDS Project Hartford

  • (2007 - Present) Clinical Core Committee, Center for Interdisciplinary Research on AIDS (CIRA)

  • (2007 - Present) Scientific Advisory Board, Center for Drug Abuse and AIDS Research (CDAAR) P30 grant at Tufts University, School of Medicine.

  • (2005 - Present) Clinical Infectious Diseases, Drug and Alcohol Dependence, Journal of Substance Abuse Treatment

  • (2005 - Present) American Society of Addiction Medicine

  • (2004 - Present) AAHIVM-American Academy of HIV Medicine

  • (2003 - Present) AIDS Reader, Annals of Internal Medicine, JAIDS, JAMA

  • (2002 - Present) Advisory Committee, Connecticut AIDS Drug Assistance Program (CADAP)

  • (2001 - Present) NIDA K Training & Career Development Subcommittee, National Institute on Drug Abuse Initial Review Group

  • (2001 - Present) American Correctional Association

  • (1997 - Present) Society for Correctional Physicians

  • (1995 - Present) Morse College, Yale University

  • Yale University School of Medicine (1995 - Present) Student Mentor

  • (1994 - Present) International AIDS Society

  • (1993 - Present) American College of Physicians

  • (1993 - Present) Infectious Disease Society of America

  • (1992 - Present) American Public Health Association


  • Studies of Alcohol and Drug Use Among MSM in Peru Lima, Peru (2011 - 2016)

    Biobehavioral Surveys, RCTs of XR-NTX among HIV+ MSM with alcohol use disorders and RCTs of early vs late initiation of ART among newly seroconverted MSM. This is a Fogarty International Global Health Equity Scholars site.

  • HIV, Opioid, Substance abuse, Malaysia Kuala Lumpur, Malaysia (2010)

    Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia

  • HIV, Tuberculosis and Drug Dependence In Iran Iran (2009)

    This involves three projects: 1. HIV and TB Coinfection Among Drug Users in Iran 2. Treatment for Opioid Dependence Among Individuals with HIV or TB 3. Prisoners and Methadone Maintenance.

  • Opioid Dependence and HIV in Malaysia Malaysia (2009)

    In 2005, the Malaysian government changed its policies toward substance abuse by implementing syringe exchange programs and methadone maintenance programs. Professor Altice has been a consultant in developing and evaluating the new policies and have since begun several different studies in Malaysia...

  • Infectious Diseases and Addiction Kuala Lumpur, Malaysia (2005)

    Funded Research Activities with Centre of Excellence in Research on AIDS (CERiA). Projects are extensive and include epidemiological studies with vulnerable populations including prisoners, female sex workers, men who have sex with men and people who inject drugs. Current studies also include...

  • HIV/AIDS, Tuberculosis and Addiction Ukraine (2005)

    Technical Assistance and Research, Developed integrated health care delivery system, Rolled out buprenorphine and methadone

  • Opioid Dependence and HIV in Ukraine Ukraine (2005)

    Since 2005, Professor Altice have trained the physicians on treatment of opioid dependence, HIV and tuberculosis. Specifically, in collaboration with his Ukrainian colleagues, They introduced the first pilot buprenorphine treatment programs in the country. They are now participating in the...

Edit this profile

Contact Info

Rick Altice, MD, MA
Patient Care Locations
Nathan Smith Clinic
15 York Street

New Haven, CT 06510
View on map...
Hartford Square West
146 Wyllys Street, Ste #2-205

Hartford, CT 06106
View on map...
Yale Infectious DiseasesYale New Haven Hospital
20 York Street

New Haven, CT 06510
View on map...
Lab Location
Yale Center for Clinical and Community Research Office270 Congress Avenue
New Haven, CT 06519
View on map...
Office Location
Yale University AIDS Program135 College Street, Ste Suite 323
New Haven, CT 06510
View on map...
Mailing Address
135 College Street
Suite 323

New Haven, CT 06510-2283